| Literature DB >> 26824662 |
Sara Mostafavi1, Hideyuki Yoshida2, Devapregasan Moodley2, Hugo LeBoité2, Katherine Rothamel2, Towfique Raj3, Chun Jimmie Ye4, Nicolas Chevrier5, Shen-Ying Zhang6, Ting Feng2, Mark Lee4, Jean-Laurent Casanova6, James D Clark7, Martin Hegen7, Jean-Baptiste Telliez7, Nir Hacohen4, Philip L De Jager3, Aviv Regev4, Diane Mathis8, Christophe Benoist8.
Abstract
Type 1 interferon (IFN) is a key mediator of organismal responses to pathogens, eliciting prototypical "interferon signature genes" that encode antiviral and inflammatory mediators. For a global view of IFN signatures and regulatory pathways, we performed gene expression and chromatin analyses of the IFN-induced response across a range of immunocyte lineages. These distinguished ISGs by cell-type specificity, kinetics, and sensitivity to tonic IFN and revealed underlying changes in chromatin configuration. We combined 1,398 human and mouse datasets to computationally infer ISG modules and their regulators, validated by genetic analysis in both species. Some ISGs are controlled by Stat1/2 and Irf9 and the ISRE DNA motif, but others appeared dependent on non-canonical factors. This regulatory framework helped to interpret JAK1 blockade pharmacology, different clusters being affected under tonic or IFN-stimulated conditions, and the IFN signatures previously associated with human diseases, revealing unrecognized subtleties in disease footprints, as affected by human ancestry.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26824662 PMCID: PMC4743492 DOI: 10.1016/j.cell.2015.12.032
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582